Binding of the complement inhibitor C4bp to serogroup B Neisseria meningitidis

Journal of Immunology

Volumn 174, Issue 10, 2005, Pages 6299-6307

  Jarva, Hanna ^a,d   Ram, Sanjay ^b   Vogel, Ulrich ^c   Blom, Anna M ^d   Meri, Seppo ^a,e  

^a UNIVERSITY OF HELSINKI   (Finland)

^b BOSTON MEDICAL CENTER   (United States)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d LUND UNIVERSITY   (Sweden)

^e UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; COMPLEMENT C4B INHIBITOR; COMPLEMENT INHIBITOR; POLYSIALIC ACID; PORIN A; PORIN B3; PROPERDIN; UNCLASSIFIED DRUG;

ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT FIXATION; COMPLEMENT SYSTEM; HOST RESISTANCE; INFECTION SENSITIVITY; MENINGITIS; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPSIS; SERUM BACTERICIDAL ACTIVITY; SIALYLATION;

EID: 18644372663     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.10.6299     Document Type: Article

References (51)

1. van Deuren, M., P. Brandtzaeg, and J. W. van der Meer. 2000, Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin. Microbiol. Rev. 13: 144-166.
2. Finne, J., D. Bitter-Suermann, C. Goridis, and U. Finne. 1987. An IgG monoclonal antibody to group B meningococci cross-reacts with developmemally regulated polysialic acid units of glycoproteins in neural and extraneural tissues. J. Immunol. 138: 4402-4407.
3. Mandrell, R. E., J. J. Kim, C. M. John, B. W. Gibson, J. V. Sugai, M. A. Apicella, J. M. Griffiss, and R. Yamasaki. 1991. Endogenous sialylation of the lipooligosaccharides of Neisseria meningitidis. J. Bacteriol. 173: 2823-2832.
4. van der Ley, P., J. E. Heckels, M, Virji, P. Hoogerhout, and J. T. Poolman. 1991. Topology of outer membrane porins in pathogenic Neisseria spp. Infect. Immun. 59: 2963-2971.
5. Minetti, C. A. S. A., J. Y. Tai, M. S. Blake, J. K. Pullen, S. M. Liang, and D. P. Remeta. 1997. Structural and functional characterization of a recombinant PorB class 2 protein from Neisseria meningitidis: conformational stability and porin activity. J. Biol. Chem. 272: 10710-10720.
6. Minetti, C. A. S. A., M. S. Blake, and D. P. Remeta. 1998. Characterization of the structure, function, and conformational stability of PorB class 3 protein from Neisseria meningitidis: a porin with unusual physicochemical properties. J. Biol. Chem. 273: 25329-25338.
7. Derrick, J. P., R. Urwin, J. Suker, I. M. Feavers, and M. C. J. Maiden. 1999. Structural and evolutionary inference from molecular variation in Neisseria porins. Infect. Immun. 67: 2406-2413.
8. Feavers, I. M., and M. C. J. Maiden. 1998. A gonococcal porA pseudogene: implications for understanding the evolution and pathogenicity of Neisseria gonorrhoeae. Mol. Microbiol. 30: 647-656.
9. Jarvis, G. A., and N. A. Vedros. 1987. Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation. Infect. Immun. 55: 174-180.
10. Hammerschmidt, S., C. Birkholz, U. Zähringer, B. D. Robertson, J. van Putten, O. Ebeling, and M. Frosch. 1994. Contribution of genes from the capsule gene complex (cps) to lipooligosaccharide biosynthesis and serum resistance in Neisseria meningitidis. Mol. Microbiol. 11: 885-896.
11. Meri, S., and M. K. Pangburn. 1994. Regulation of alternative pathway complement activation by glycosaminoglycans: specificity of the polyanion binding site on factor H. Biochem. Biophys. Res. Commun. 198: 52-59.
12. Pollard, A. J., and C. Frasch. 2001. Development of natural immunity to Neisseria meningitidis. Vaccine 19: 1327-1346.
13. Blom, A. M. 2002. Structural and functional studies of complement inhibitor C4b-binding protein. Biochem. Soc. Transact. 30(Pt. 6): 978-982.
14. Blom, A. M., L. Kask, and B. Dahlback. 2001. Structural requirements for the complement regulatory activities of C4BP. J. Biol. Chem. 276: 27136-27144.
15. Berggård, K., E. Johnsson, F. R. Mooi, and G. Lindahl. 1997. Bordetella pertussis binds the human complement regulator C4BP: role of filamentous hemagglutinin. Infect. Immun. 65: 3638-3643.
16. Johnsson, E., A. Thern, B. Dahlback, L. O. Heden, M. Wikstrom, and G. Lindahl. 1997. Human C4BP binds to the hypervariable N-terminal region of many members in the streptococcal M protein family. Adv. Exp. Med. Biol. 418: 505-510.
17. Prasadarao, N. V., A. M. Blom. B. O. Villoutreix, and L. C. Linsangan. 2002. A novel interaction of outer membrane protein A with C4b binding protein mediates serum resistance of Escherichia coli K1. J. Immunol. 169: 6352-6360.
18. Carlsson, F., K. Berggard, M. Stalhammar-Carlemalm, and G. Lindahl. 2003. Evasion of phagocytosis through cooperation between two ligand-binding regions in Streptococcus pyogenes M protein. J. Exp. Med. 198: 1057-1068.
19. Ram, S., M. Cullinane, A. M. Blom, S. Gulati, D. P. McQuillen, B. G. Monks, C. O'Connell, R. Boden, C. Elkins, M. K. Pangburn, B. Dahlback, and P. A. Rice. 2001. Binding of C4b-binding protein to porin: a molecular mechanism of serum resistance of Neisseria gonorrhoeae. J. Exp. Med. 193: 281-295.
20. Dahlbäck, B. 1983. Purification of human C4b-binding protein and formation of its complex with vitamin K-dependent protein S. Biochem. J. 209: 847-856.
21. Blom, A. M., L. Kask, and B. Dahlbäck. 2001. Structural requirements for the complement regulatory activities of C4BP. J. Biol. Chem. 276: 27136-27144.
22. Härdig, Y., A. Hillarp, and B. Dahlbäck. 1997. The amino-terminal module of the C4b-binding protein α-chain is crucial for C4b binding and factor I-cofactor function. Biochem. J. 323(Pt. 6): 469-475.
23. Coligan, J. E., A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober. 1988. Fragmentation of immunoglobulin G. In Current Protocols in Immunology. R. Coico, ed. John Wiley & Sons, Inc., New York, p. 2.8.2-2.8.4.
24. Holten, E. 1979. Serotypes of Neisseria meningitidis isolated from patients in Norway during the first six months of 1978. J. Clin. Microbiol. 9: 186-188.
25. Tommassen, J., P. Vermeij, M. Struyve, R. Benz, and J. T. Poolman. 1990. Isolation of Neisseria meningitidis mutants deficient in class 1 (PorA) and class 3 (PorB) outer membrane proteins. Infect. Immun. 58: 1355-1359.
26. Ram, S., A. D. Cox, J. C. Wright, U. Vogel, S. Getzlaff, R. Boden, J, Li, J. S. Plested, S. Meri, S. Gulati, et al. 2003. Neisserial lipooligosaccharide is a target for complement component C4b: inner core phosphoethanolamine residues define C4b linkage specificity. J. Biol. Chem. 278: 50853-50862.
27. Vogel, U., H. Claus, G. Heinze, and M. Frosch. 1999. Role of lipopolysaccharide sialylation in serum resistance of serogroup B and C meningococcal disease isolates. Infect. Immun. 67: 954-957.
28. Ram, S., F. G. Mackinnon, S. Gulati, D. P. McQuillen. U. Vogel, M. Frosch, C. Elkins, H. K. Guttormsen, L. M. Wetzler, M. Oppermann, M. K. Pangburn, and P. A. Rice. 1999. The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidis. Mol. Immunol 36: 915-928.
29. Matsunami, T., and J. A. Kolmer. 1918. The relation of the meningococcidal activity of the blood to resistance to virulent meningococci. J. Immunol. 3: 201-212.
30. Ross, S. C., P. J. Rosenthal, H. M. Berberich, and P. Densen. 1987. Killing of Neisseria meningitidis by human neutrophils: implications for normal and complement-deficient individuals. J. Infect. Dis. 155: 1266-1275.
31. Brandtzaeg, P., T. E. Mollnes, and P. Kierulf. 1989. Complement activation and endotoxin levels in systemic meningococcal disease. J. Infect. Dis. 160: 58-65.
32. Brandtzaeg, P., P. Kierulf, P. Gaustad, A. Skulberg, J. N. Bruun, S. Halvorsen, and E. Sorensen. 1989. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J. Infect. Dis. 159: 195-204.
33. Hazelzet, J. A., R. de Groot, G. van Mierlo, K. F. M. Joosten, E. van der Voort, A. Eerenberg, M. H. Suur, W. C. J. Hop, and C. E. Hack. 1998. Complement activation in relation to capillary leakage in children with septic shock and purpura. Infect. Immun. 66: 5350-5356.
34. Brandtzaeg, P., K. Høgåsen, P. Kierulf, and T. E. Mollnes. 1996. The excessive complement activation in fulminant meningococcal septicemia is predominantly caused by alternative pathway activation. J. Infect. Dis. 173: 647-655.
35. Vogel, U., H. Claus, G. Heinze, and M. Frosch. 1997. Functional characterization of an isogenic meningococcal α-2,3-sialyltransferase mutant: the role of lipooligosaccharide sialylation for serum resistance in serogroup B meningococci, Med. Microbiol Immunol. 186: 159-166.
36. Vogel, U., A. Weinberger, R. Frank, A. Muller, J. Kohl, J. P. Atkinson, and M. Frosch. 1997. Complement factor C3 deposition and serum resistance in isogenic capsule and lipooligosaccharide sialic acid mutants of serogroup B Neisseria meningitidis. Infect. Immun. 65: 4022-4029.
37. Garred, P., T. E. Michaelsen, G. Bjune, S. Thiel, and A. Svejgaard. 1993. A low serum concentration of mannan-binding protein is not associated with serogroup B or C meningococcal disease. Scand. J. Immunol. 37: 468-470.
38. Hibberd, M. L., M. Sumiya, J. A. Summerfield, R. Booy, M. Levin, and the Meningococcal Research Group. 1999. Association of variants of the gene fro mannose-binding lectin with susceptibility to meningococcal disease. Lancet 353: 1049-1053.
39. Jack, D. L., A. W. Dodds, N. Anwar, C. A. Ison, A. Law, M. Frosch, M. W. Turner, and N. J. Klein. 1998. Activation of complement by mannose-binding lectin on isogenic mutants of Neisseria meningitidis serogroup B. J. Immunol. 160: 1346-1353.
40. Jack, D. L., G. A. Jarvis, C. L. Booth, M. W. Turner, and N. J. Klein. 2001. Mannose-binding lectin accelerates complement activation and increases serum killing of Neisseria meningitidis serogroup C. J. Infect. Dis, 184: 836-845.
41. Estabrook, M. M., D. L. Jack, N. J. Klein, and G. A. Jarvis, 2004. Mannose-binding lectin binds to two major outer membrane proteins, opacity protein and porin, of Neisseria meningitidis. J. Immunol. 172: 3784-3792.
42. Devoe, I. W., and J. E. Gilchrist. 1973. Release of endotoxin in the form of cell wall blebs during in vitro growth of Neisseria meningitidis. J. Exp. Med. 138: 1156-1167.
43. Bjerre, A., B. Brusletto, T. E. Mollnes, E. Fritzsønn, E. Rosenqvist, E. Wedege. E. Namork, P. Kierulf, and P. Brandtzaeg. 2002. Complement activation induced by purified Neisseria meningitidis lipopolysaccharide (LPS), outer membrane vesicles, whole bacteria, and an LPS-free mutant. J. Infect. Dis. 185: 220-228.
44. Drogari-Apiranthitou, M., E. J. Kuijper, N. Dekker, and J. Dankert. 2002. Complement activation and formation of the membrane attack complex on serogroup B Neisseria meningitidis in the presence or absence of serum bactericidal activity. Infect. Immun. 70: 3752-3758.
45. Mandrell, R. E., A. J. Lesse, J. V. Sugai, M. Shero, J. M. Griffiss, J. A. Cole, N. J. Parsons, H. Smith, S. A. Morse, and M. A. Apicella. 1990. In vitro and in vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope structure by sialylation. J. Exp. Med. 171: 1649-1664.
46. Vogel, U., S. Hammerschmidt, and M. Frosch. 1996. Sialic acids of both the capsule and the sialylated lipooligosaccharide of Neisseria meningitis serogroup B are prerequisites for virulence of meningococci in the infant rat. Med. Microbiol Immunol 185: 81-87.
47. Hammerschmidt, S., A. Muller, H. Sillmann, M. Muhlenhoff, R. Borrow, A. Fox, J. van Putten, W. D. Zollinger, R. Gerardy-Schahn, and M. Frosch. 1996. Capsule phase variation in Neisseria meningitidis serogroup B by slipped-strand mispairing in the polysialyllransferase gene (siaD): correlation with bacterial invasion and the outbreak of meningococcal disease. Mol. Microbiol 20: 1211-1220.
48. de Vries, F. P., A. van Der Ende, J. P. van Putten, and J. Dankert. 1996. Invasion of primary nasopharyngeal epithelial cells by Neisseria meningitidis is controlled by phase variation of multiple surface antigens. Infect. Immun. 64: 2998-3006.
49. Dahlbäck, B., and J. Stenflo. 1981. High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b-binding protein. Proc. Natl. Acad. Sci. USA 78: 2512-2516.
50. Dahlbäck, B. 1986. Inhibition of protein Ca cofactor function of human and bovine protein S by C4b-binding protein, J. Biol. Chem. 261: 12022-12027.
51. Faust, S. N., M. Levin, O. B. Harrison, R. D. Goldin, M. S. Lockhart, S. Kondaveeti, Z. Laszik, C. T. Esmon, and R. S. Heyderman. 2001. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N. Engl. J. Med. 345: 408-416.